HHS Selects 15 New Drugs for Medicare Part D Price Negotiations
· 4d · on MSN
Latest Medicare price drug negotiations includes Ozempic, Wegovy
Ozempic and Wegovy make the list of the next 15 drugs in Medicare negotiations: HHS
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer treatment Calquence, GSK’s chronic obstructive pulmonary disorder (COPD) drug Breo Ellipta, and AbbVie’s antipsychotic medication Vraylar.
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started, so current drug prices are unaffected.
Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo Nordisk blockbusters Wegovy and Ozempic, are slated for price talks.
As of Monday, FDA commissioner Robert Califf, Department of Health and Human Services (HHS) Secretary Xavier Becerra, Medicare director Meena Seshamani, and FDA Center for Drug Evaluation and Research director Patrizia Cavazzoni have retired or intend to retire prior to Trump's inauguration on Jan. 20.
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and Medicaid Innovation at CMS.
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.
Paul Mango, a senior health official during President-elect Donald Trump's first term who was a member of Trump's current transition team, has died at 65. | Paul Mango, a senior health official during President-elect Donald Trump's first term who was a member of Trump's current transition team,
A new Health and Human Services report is calling for greater transparency in long-term care ownership, calling out private equity investors.
Among the dozens of Biden-era executive orders he rescinded on day one, President Trump nixed one that aimed to explore new health care payment models that would lower prescription costs for
Kennedy’s potential ascent as HHS secretary brings promise for backers of alternative-health approaches, while skeptics say those treatments are often unproven.
A Louisiana grassroots organization is working with physicians around the state to prevent the nomination of Robert F. Kennedy, Jr. as Secretary of the Department of Health and Human Services.
More than 23 million Americans, a record number, signed up for Affordable Care Act Marketplace coverage for 2025 before the Jan. 15 deadline. Over 45 million Americans are covered through the ACA's Marketplace and Medicaid expansion,
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback